Novatek Nova-Stability: Can Your Stability Programme Keep Up with Modern Pharma?

Overview: How Novatek Nova-Stability’s Digital Stability Management Platform Transforms Pharmaceutical Quality Control

Novatek Nova-Stability is a laboratory information management system for planning, executing, monitoring, and analysing product stability studies across pharmaceutical and healthcare-product lifecycles. It brings study protocols, sample inventories, time-point schedules, test results, chain-of-custody information, and reporting into a single operational environment, supporting accelerated, long-term, intermediate, transport, storage, photostability, stress, and forced-degradation studies.

Stability programmes can become operationally complex when laboratories rely on disconnected systems, manual scheduling, spreadsheet calculations, and fragmented records. Nova-Stability addresses this bottleneck through workflow automation and a built-in statistical-analysis capability, applying established methods such as regression analysis, ANOVA, ANCOVA, data pooling, and Arrhenius modelling to stability data and shelf-life assessment. This is structured statistical automation rather than a publicly described machine-learning or generative-AI platform.

For laboratory, quality, and product-development operations, the system can coordinate sample pulls, issue notifications and escalations, track barcode-linked samples, and produce study, scheduling, productivity, investigation, results, and statistical reports. Consolidating data and automating calculations can reduce manual administrative work and the risk of missed time points or calculation errors, while delivering shelf-life analyses in seconds and giving teams more timely information for product-quality decisions.

Last checked on September 30, 2026: Nova-Stability remains actively marketed by Novatek International, with the latest identified update being a September 2026 customer story on its deployment across more than 11 Sun Pharma manufacturing sites

What is Novatek Nova-Stability?

Novatek Nova-Stability is a digital stability-study management system within the LIMS System category, used to plan, schedule, execute, track, analyse, and report pharmaceutical and biotechnology product stability studies, including long-term, accelerated, photostability, transport, and stress-testing programmes. It is intended for pharmaceutical and biotech quality-control, R&D, manufacturing, and laboratory operations teams that need to manage protocols, samples, storage conditions, testing time points, results, and shelf-life evaluations. The platform combines workflow automation and integrations with laboratory systems and equipment with built-in statistical methods—including regression, ANOVA, ANCOVA, data pooling, and Arrhenius modelling—rather than publicly described machine-learning capabilities.

Intended Use and Limitations

• Nova-Stability is actively marketed by Novatek International as a stability-study management system for pharmaceutical, biotechnology, and regulated healthcare-product operations.

• Novatek published a September 2026 customer account stating that Sun Pharmaceutical Industries uses Nova-Stability across more than 11 sites for its stability-testing process.

• The Sun Pharma account describes use of the platform for data integrity, traceability, and audit readiness, and reports no major regulatory queries related to submitted stability-summary data; this is customer-reported evidence rather than an independent audit.

• Nova-Stability supports a documented range of stability-study types, including long-term, accelerated, intermediate, photostability, storage, transport, stress, and forced-degradation studies.

• The product includes configurable workflows for protocols, sample scheduling and pulls, chain of custody, study monitoring, alerts, escalations, and reporting.

• Nova-Stability provides built-in statistical methods for shelf-life assessment, including regression, ANOVA, ANCOVA, data pooling, and Arrhenius modelling; the product is not publicly described as using machine learning or generative AI.

• Novatek states that the system can operate standalone or integrate with Nova-LIMS, third-party LIMS, ERP, MES, software applications, and laboratory equipment.

• Novatek’s public materials describe its quality-software portfolio as supporting 21 CFR Part 11–compliant and validated operations; buyers should confirm the precise validation status and configuration of a specific Nova-Stability deployment.

• Novatek’s published privacy policy states that it does not sell or rent personal data and describes rights to access, correct, delete, restrict, or object to relevant processing; product-specific HIPAA or GDPR certification is not specified in the reviewed Nova-Stability materials.